logo

CYH

Community Health·NYSE
--
--(--)
--
--(--)
4.64 / 10
Netural

Fundamental assessment rates CYH at 4.6/10. Positive factors include PB‑ROE, cash‑to‑market value, and strong YoY earnings and profit growth. Negative aspects are revenue‑to‑market and asset‑to‑market ratios, indicating valuation pressure despite solid cash position.

Fundamental(4.64)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value3.78
Score1/3
Weight12.92%
1M Return3.16%
Net cash flow from operating activities per share (YoY growth rate %)
Value13.36
Score1/3
Weight3.24%
1M Return0.81%
PB-ROE
Value-1.03
Score2/3
Weight3.34%
1M Return0.81%
Basic earnings per share (YoY growth rate %)
Value197.69
Score2/3
Weight6.52%
1M Return1.70%
Total profit (YoY growth rate %)
Value355.83
Score3/3
Weight22.11%
1M Return5.14%
Net cash flow from operating activities (YoY growth rate %)
Value13.13
Score2/3
Weight6.29%
1M Return1.55%
Cash-UP
Value1.12
Score1/3
Weight2.57%
1M Return0.66%
Diluted earnings per share (YoY growth rate %)
Value196.67
Score2/3
Weight4.77%
1M Return1.25%
Asset-MV
Value-0.55
Score1/3
Weight6.24%
1M Return1.77%
Cash-MV
Value2.77
Score3/3
Weight32.01%
1M Return6.61%
Is CYH undervalued or overvalued?
  • CYH scores 4.64/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 5.41% net margin, 0.81 P/E ratio, -0.49 P/B ratio, and 197.69% earnings growth, these metrics solidify its Netural investment rating.